Navigation Links
B. Braun Awarded Premier Healthcare Alliance Contract for Dual-Source IV
Date:8/27/2013

BETHLEHEM, Pa., Aug. 27, 2013 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) announced today that it has been selected by Premier, a collaborative nationwide healthcare alliance of approximately 2,900 hospitals and health systems, with a dual-source IV Solutions contract award through January 31, 2020.

"B.Braun's long-term investment in the IV product space has been rewarded, recognized and valued by the Premier membership," said Scott Quilty, Corporate Vice President at B.Braun.

Through these new contracts, Premier members can benefit from B.Braun's IV fluids, bag-based drug delivery and TPN nutrition along with its leading line of needle-free devices and IV sets, and its multiple platforms of infusion pump technology.

"This recognition from Premier is significant as it underscores B.Braun's ability to produce and deliver environmentally friendly, high-quality, IV solution containers," said Quilty. "We are confident that Premier members will benefit from our full range of IV products, which are designed to enhance both clinician and patient safety," added Quilty.

In a highly competitive IV marketplace, B.Braun has seized the leadership role with its product development and investment across a range of products that are vital to our customers and the patients that our customers care for on a daily basis.

About B. Braun

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.


'/>"/>
SOURCE B. Braun Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Patient and Healthcare Worker Safety Major Areas of Focus at B.Braun
2. B. Braun Smart Infusion Pump Technology to be Featured in Integrating the Healthcare Enterprise (IHE) Interoperability Demonstration at AAMI 2013
3. B. Braun Committed To Improving Patient Safety
4. B. Braun Reveals Customer Satisfaction Survey
5. B. Braun Committed to Protecting Healthcare Workers from Exposure to Hazardous Drugs
6. B. Braun Launches New Patient Website
7. B. Braun Smart Infusion Pump Technology Advances Patient Safety and Treatment Efficiency
8. B. Braun Joins National Health Organization Supporting Environmental Practices
9. Novan Awarded $7.8 Million Contract by BARDA to Develop a Medical Countermeasure for Thermal Burns
10. Fountain Valley Regional Medical Center Becomes Orange Countys First Hospital Awarded Advanced Certification In Inpatient Diabetes Care
11. aTyr Pharma Awarded Two Patents from USPTO to Support Development of New Therapeutics Based on Physiocrine Biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology:
(Date:4/24/2017)... Boca Raton, Florida (PRWEB) , ... April 24, 2017 , ... ... natural chai teas, announced its products are now available for purchase on RevNutrition.com, a ... ancient form of tea first produced and popularized in ancient India and Siam. It ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... healthcare compliance and credentialing solutions, today announced that Kyle Allain has joined the ... Cactus Provider Management sales and operations, including provider, payor and managed care solutions. ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research ... of this type of healthcare model in the diagnosis and treatment of brain ...
(Date:4/24/2017)... IL (PRWEB) , ... April 24, 2017 , ... Rod ... the Senior Housing News website. , Rod has been at the forefront of Gardant ... company’s culture. As CEO, Rod has overseen the opening of more than 40 new ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for ... The good news for single women is that she put all the words in ... April 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her ...
Breaking Medicine News(10 mins):